Cargando…

Noninvasive Testing and Surrogate Markers in Invasive Fungal Diseases

Invasive fungal infections continue to increase as at-risk populations expand. The high associated morbidity and mortality with fungal diseases mandate the continued investigation of novel antifungal agents and diagnostic strategies that include surrogate biomarkers. Biologic markers of disease are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thompson, George R, Boulware, David R, Bahr, Nathan C, Clancy, Cornelius J, Harrison, Thomas S, Kauffman, Carol A, Le, Thuy, Miceli, Marisa H, Mylonakis, Eleftherios, Nguyen, M Hong, Ostrosky-Zeichner, Luis, Patterson, Thomas F, Perfect, John R, Spec, Andrej, Kontoyiannis, Dimitrios P, Pappas, Peter G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Invited Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124589/ https://www.ncbi.nlm.nih.gov/pubmed/35611348 http://dx.doi.org/10.1093/ofid/ofac112

Ejemplares similares

Disseminated Cryptococcosis With Brain Involvement in Patients With Chronic Lymphoid Malignancies on Ibrutinib
por: Messina, Julia A., et al.
Publicado: (2017)

Coronavirus Disease 2019–Associated Invasive Fungal Infection
por: Baddley, John W, et al.
Publicado: (2021)

Efficacy of T2 Magnetic Resonance Assay in Monitoring Candidemia after Initiation of Antifungal Therapy: the Serial Therapeutic and Antifungal Monitoring Protocol (STAMP) Trial
por: Mylonakis, Eleftherios, et al.
Publicado: (2018)

120. An open-label comparative trial of SUBA-itraconazole (SUBA) versus conventional itraconazole (c-itra) for treatment of proven and probable endemic mycoses (MSG-15): a pharmacokinetic (PK) and adverse Event (AE) analysis
por: Pappas, Peter G, et al.
Publicado: (2021)

Real-world Use of Mold-Active Triazole Prophylaxis in the Prevention of Invasive Fungal Diseases: Results From a Subgroup Analysis of a Multicenter National Registry
por: Nguyen, M Hong, et al.
Publicado: (2023)

1248. Efficacy and Safety of Oral Ibrexafungerp in 41 Patients with Refractory Fungal Diseases, Interim Analysis of a Phase 3 Open-label Study (FURI)
por: Alexander, Barbara D, et al.
Publicado: (2020)

Hope on the Horizon: Novel Fungal Treatments in Development
por: Rauseo, Adriana M, et al.
Publicado: (2020)

Detecting Infections Rapidly and Easily for Candidemia Trial (DIRECT1): A Prospective, Multicenter Study of the T2Candida Panel
por: Clancy, Cornelius J, et al.
Publicado: (2017)

Statistical validation of surrogate outcome measures
por: Buyse, Marc
Publicado: (2011)

123. Oral Ibrexafungerp Outcomes by Fungal Disease in Patients from an Interim Analysis of a Phase 3 Open-label Study (FURI)
por: Pappas, Peter G, et al.
Publicado: (2021)

Multicenter Registry of Patients Receiving Systemic Mold-Active Triazoles for the Management of Invasive Fungal Infections
por: Ostrosky-Zeichner, L., et al.
Publicado: (2022)

Noninvasive assessment of arterial function in children: clinical applications
por: Aggoun, Y, et al.
Publicado: (2002)

Clinical prediction rules for invasive candidiasis in the ICU: ready for prime time?
por: Ostrosky-Zeichner, Luis
Publicado: (2011)

Are All Patients with Cancer at Heightened Risk for Severe Coronavirus Disease 2019 (COVID-19)?
por: Chamilos, Georgios, et al.
Publicado: (2020)

Drunk Without Drinking: A Case of Auto-Brewery Syndrome
por: Akhavan, Bobak J., et al.
Publicado: (2019)

Isavuconazole: Mechanism of Action, Clinical Efficacy, and Resistance
por: Ellsworth, Misti, et al.
Publicado: (2020)

Investigational Agents for the Treatment of Resistant Yeasts and Molds
por: Seiler, Garret T., et al.
Publicado: (2021)

2045. Pitfalls in the Use of MALDI TOF Mass Spectrometry for the Identification of Problematic Yeast Isolates from a Historical Collection
por: Pachar, Monica, et al.
Publicado: (2018)

Correction to: Noninvasive Testing and Surrogate Markers in Invasive Fungal Diseases
Publicado: (2022)

144. MSG-15: Pharmacokinetic (PK), Adverse Events (AEs), and Tolerability Data from an Open Label Randomized Clinical Trial (RCT) Comparing Oral Suba-itraconazole (SUBA-ITC) to Conventional Itraconazole (C-ITC) for Treatment of Endemic Mycosis (EM)
por: Pappas, Peter G, et al.
Publicado: (2020)

1718. Rezafungin Clinical Safety and Efficacy in Patients With Candidemia and/or Invasive Candidiasis in the Randomized, Double-Blind, Multicenter, Phase 2 STRIVE Study
por: Thompson, George R, et al.
Publicado: (2018)

824 An Open-Label Phase 3 Study of Isavuconazole (VITAL): Focus on Mucormycosis
por: Marty, Francisco M., et al.
Publicado: (2014)

The NLRP1 and CARD8 inflammasomes
por: Taabazuing, Cornelius Y., et al.
Publicado: (2020)

Mind the gap: The hospital breakroom
por: Ellsworth, Misti, et al.
Publicado: (2020)

Microarray Profiling of Lymphocytes in Internal Diseases With an Altered Immune Response: Potential and Methodology
por: Gladkevich, Anatoliy, et al.
Publicado: (2005)

Brush swab as a noninvasive surrogate for tissue biopsies in epigenomic profiling of oral cancer
por: Viet, Chi T., et al.
Publicado: (2021)

Accuracy of Noninvasive Intraocular Pressure or Optic Nerve Sheath Diameter Measurements for Predicting Elevated Intracranial Pressure in Cryptococcal Meningitis
por: Nabeta, Henry W., et al.
Publicado: (2014)

Post-exposure prophylaxis with isavuconazole after occupational exposure to Rhizopus
por: Al-Obaidi, Mohanad, et al.
Publicado: (2018)

1196. Is the Weekend Staff Really to Blame? Challenges in Isolation Compliance at an Academic Tertiary Care Center
por: Bassett, Sonia, et al.
Publicado: (2019)

Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial
por: Perfect, John R., et al.
Publicado: (2018)

In response to: “A new noninvasive method can effectively assess intracranial compliance. Letter to the Editor”
por: Ballestero, Matheus, et al.
Publicado: (2023)

Noninvasive surrogates of intracranial pressure: another piece added with magnetic resonance imaging of the cerebrospinal fluid thickness surrounding the optic nerve
por: Geeraerts, Thomas
Publicado: (2013)

369. Using Hybrid Models and Blockchain Technology as a Means to Develop a Novel Propensity Score for Candidemia and Invasive Candidiasis
por: Rao, Arni Sr Srinivasa, et al.
Publicado: (2018)

Prevention and Treatment of Yeast and Endemic Fungal Infections
por: Al Hammadi, Ahmed, et al.
Publicado: (2019)

Invasive Mold Infections Following Hurricane Harvey—Houston, Texas
por: Toda, Mitsuru, et al.
Publicado: (2023)

Histoplasmosis and Blastomycosis in Solid Organ Transplant Recipients
por: Kauffman, Carol A., et al.
Publicado: (2015)

Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19
por: Thompson III, George R, et al.
Publicado: (2020)

Outpatient Infection Prevention: A Practical Primer
por: Steinkuller, Fozia, et al.
Publicado: (2018)

Trends of Azole Antifungal Prescription in the United States: Medicare Part D Provider Utilization and Payment Data Analysis
por: Al-Obaidi, Mohanad M, et al.
Publicado: (2023)

Spatio-temporal determinants of mental health and well-being: advances in geographically-explicit ecological momentary assessment (GEMA)
por: Kirchner, Thomas R., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_t0pgb9ig9hldlvk7ivrqsb7gbo